Lucid Diagnostics
LUCD
$0.68
Share price
0.60%
Change (1 day)
-53.53%
Change (1 year)
Categories
Lucid Diagnostics (LUCD) - Cash on Hand
Cash on Hand as of December 2023 : $18.89 M
According to Lucid Diagnostics's latest financial reports the company has $18.89 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Lucid Diagnostics - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $22.47 M | -58.11% |
| 2021-12-31 | $53.65 M | 48238.74% |
| 2020-12-31 | $0.11 M | -29.03% |
| 2019-12-31 | $0.15 M |